Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ovarian Neoplasms 11Prostatic Neoplasms 7Fallopian Tube Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Prostatic Neoplasms, Castration-Resistant 2Carcinoma, Ovarian Epithelial 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC,Extensive Stage 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-sensitive Prostate Cancer 1Lung Neoplasms 1Laryngeal Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Hemangiosarcoma 1Head and Neck Neoplasms 1Glioblastoma 1Endometrial Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1

Interventions

Magnetic Resonance Spectroscopy 15Specimen Handling 12Cisplatin 9Platinum 71,2-diaminocyclohexaneplatinum II citrate 7pembrolizumab 6Radiotherapy, Intensity-Modulated 6Cetuximab 6Biopsy 6Radiation 5Carboplatin 5Radiotherapy 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3X-Rays 3Taxes 3Standard of Care 3Paclitaxel 3Immunoglobulin G 3Disulfides 3ipatasertib 2Ultrasonography 2Practice Guidelines as Topic 2Nivolumab 2Interviews as Topic 2Fluorodeoxyglucose F18 2Drug Therapy 2Docetaxel 2Bevacizumab 2trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mouth Neoplasms × niraparib × 90 days × Clear all
NCT05784012 2026-06-04

RADIAN

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Phase 1/2 Active not recruiting
34 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡